Freedom (FRHC) had the best quarter between 2014 and 2015 by a US stock with a market cap of $10B+ in Q4 2015, returning 160%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Freedom (FRHC) | Q4 2015 | 160% |
Celsius (CELH) | Q1 2015 | 149.97% |
Celsius (CELH) | Q2 2015 | 126.37% |
Celsius (CELH) | Q1 2014 | 117.92% |
Leonardo DRS, Inc Common Stock (DRS) | Q3 2014 | 117.52% |
Builders FirstSource (BLDR) | Q2 2015 | 93.67% |
Neurocrine Biosciences (NBIX) | Q1 2015 | 75.79% |
TKO (TKO) | Q1 2014 | 75.2% |
Exelixis (EXEL) | Q1 2015 | 74.83% |
Neurocrine Biosciences (NBIX) | Q1 2014 | 73.68% |
Axon Enterprise (AXON) | Q4 2014 | 72.62% |
QXO (QXO) | Q4 2014 | 69.23% |
Paycom Soft (PAYC) | Q4 2014 | 62.43% |
Advanced Micro Devices (AMD) | Q4 2015 | 62.15% |
Zillow (ZG) | Q2 2014 | 61.41% |
Wayfair (W) | Q1 2015 | 60.68% |
Ionis Pharmaceuticals (IONS) | Q4 2014 | 58.31% |
Netflix (NFLX) | Q2 2015 | 57.35% |
Exelixis (EXEL) | Q3 2015 | 55.83% |
First Solar (FSLR) | Q4 2015 | 55.05% |
Ionis Pharmaceuticals (IONS) | Q4 2015 | 53.14% |
NetEase (NTES) | Q4 2015 | 50.53% |
Flutter Entertainment (FLUT) | Q4 2015 | 48.86% |
Incyte (INCY) | Q4 2014 | 48.78% |
Exelixis (EXEL) | Q2 2015 | 47.45% |
